KatieM Wales
Paulconsterdine101 London
tremcoillbruck East Midlands
SarahW West Midlands
Channy London
CearaB5 Northern Ireland
Novato, Calif, August 2, 2010 BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that it has completed the Phase 1 clinical study of BMN 195, a small molecule utrophin up-regulator...
Tags: utrophin upregulation, Biomarin, BMN 195.